Breaking News
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
February 15, 2019 - 6 out of 10 hip replacements last 25 years or longer
February 15, 2019 - Health Tip: What You Should Know About Antibiotics
February 15, 2019 - New research challenges medical consensus that adenoids and tonsils significantly shrink during teenage years
February 15, 2019 - Discovery of weakness in a rare cancer could be exploited with drugs
February 15, 2019 - UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s
February 15, 2019 - New rules requiring female athletes to lower testosterone levels are based on flawed data
February 15, 2019 - Researchers comprehensively sequence the human immune system
February 15, 2019 - Researchers study animal venoms to identify new medicines for treating diseases
February 15, 2019 - Movement of wrist bones revealed by MRI and computer modeling
February 15, 2019 - Philips introduces new premium digital X-ray room to help shorten patient wait times
February 15, 2019 - Women fare worse than men following aortic heart surgery, study finds
February 15, 2019 - High-protein and low-calorie diet helps older adults lose weight safely, shows study
February 15, 2019 - Drug microdosing effects may not measure up to big expectations
February 15, 2019 - Discharged, Dismissed: ERs Often Miss Chance To Set Overdose Survivors On ‘Better Path’
February 15, 2019 - A digitized lab environment to be showcased at smartLAB 2019
February 15, 2019 - Scientists uncover main mechanisms of fluconazole drug resistance
February 15, 2019 - New study seeks to understand how colibactin causes cancer
February 15, 2019 - Photoacoustic imaging accurately measures the temperature of deep tissues
February 15, 2019 - Large study finds no association between phthalate exposure and breast cancer risk
February 15, 2019 - New research explains presence of ‘natural’ magnetism in human cells
February 15, 2019 - Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients
February 15, 2019 - Scientists shed light on damaging cell effects linked to aging
February 15, 2019 - Celiac disease may be caused by stomach bug in childhood
February 15, 2019 - NHS performance figures highlight the true scale of Emergency Department crisis
February 15, 2019 - High intensity exercise may improve health by increasing gut microbiota diversity
February 15, 2019 - Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia
February 15, 2019 - Couples creating art or playing board games release ‘love hormone’
February 15, 2019 - Glimpsing The Future At Gargantuan Health Tech Showcase
February 15, 2019 - Common herbicide found to increase the risk of lymphoma
February 15, 2019 - Over-abundance of energy to cells could increase cancer risk
February 15, 2019 - Oxford Genetics appoints Jocelyne Bath as new Chief Operating Officer
February 15, 2019 - Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors
February 15, 2019 - Large-scale clinical trial begins to study liver transplantation between people with HIV
February 15, 2019 - Cannabis use among adolescents linked with increased risk of depression in adulthood
February 15, 2019 - Fractures, head injuries common in electric scooter accidents, UCLA study finds
February 15, 2019 - Prenatal maternal depression has important consequences for infant temperament, study shows
February 15, 2019 - Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer
February 15, 2019 - Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome
February 15, 2019 - Certain birthmarks warrant quick treatment, pediatricians say
February 15, 2019 - New machine learning method predicts if atypical ductal hyperplasia will turn cancerous
February 15, 2019 - Whole-genome sequencing and sharing real-time data could limit spread of foodborne bacteria
February 15, 2019 - FDA warns doctor for illegally marketing unapproved implantable device
February 15, 2019 - New injury documentation tool may provide better evidence for elder abuse cases
February 15, 2019 - Physiological age is a better predictor of survival than chronological age, shows study
February 15, 2019 - New study reveals high success rate for hip and knee replacements
February 15, 2019 - Prenatal exposures to BPA may pose threat to human ovarian function
February 15, 2019 - Suspicious spots on the lungs of children with rhabdomyosarcoma do not behave like metastases
February 15, 2019 - Diet drinks daily could raise stroke risk says study
February 15, 2019 - Many Systematic Reviews Do Not Fully Report Adverse Events
February 15, 2019 - Seven tips to protect your child from burns
February 15, 2019 - Keynote speakers announced for CBD Expo MIDWEST
February 15, 2019 - New DNA methylation GrimAge tool allows you to predict lifespan and healthspan
February 15, 2019 - New AI-driven platform analyze how pathogens infect human cells
February 15, 2019 - Increased activity of EHMT2 gene deficient neurons could cause autism in humans
February 15, 2019 - Recurring UTIs may mask symptoms of bladder or kidney cancer
February 15, 2019 - Researchers conduct extensive comparison of drugs used in treating neuroendocrine tumors
February 15, 2019 - Depression prevention for pregnant women and new mothers – new recommendations
New high-sensitivity blood tests could aid faster diagnosis and treatment for heart attack

New high-sensitivity blood tests could aid faster diagnosis and treatment for heart attack

image_pdfDownload PDFimage_print

When diagnosing a heart attack, accuracy and timing are everything.

A new test designed to better measure levels of troponin, a protein released when the heart muscle is damaged, could help emergency department physicians provide faster diagnosis and appropriate treatment.

Known as high-sensitivity troponin (hsTn) assays, these blood tests became available for clinical use in Europe in 2010. One type was approved by the U.S. Food and Drug Administration in January 2017.

Assays to measure troponin have been commonplace procedure for nearly 30 years. They’re part of a standard range of diagnostics, including electrocardiogram and coronary angiography, which help doctors confirm a heart attack.

But the high-sensitivity blood tests, says Frederick Korley, M.D., Ph.D., can measure very low quantities of troponin and can therefore tell doctors whether a patient is having a heart attack or not shortly after symptoms begin.

Existing tests are less accurate in the initial hours after a heart attack begins, which can delay crucial intervention and clog waiting rooms as patients have to wait for repeat testing to be able to definitively rule out a heart attack.

“Now, we can give you that answer in a shorter timespan,” says Korley, an assistant professor of emergency medicine at the University of Michigan Medical School.

The new tests, not yet in widespread domestic use, aren’t perfect, says Korley, who wrote a JAMA Cardiology editorial about their potential and limitations. Greater precision, he notes, also could lead to overdiagnosis and undue hospitalization.

Still, “it’s a big deal,” says Korley, “and it’s going to be paradigm-shifting.”

Why is this new test significant?

Korley: The high-sensitivity assay is able to measure tenfold lower concentrations of troponin -; much smaller amounts than the current assay is able to. It takes some time for the proteins to leave the heart and get into the bloodstream, so this new test can tell us a lot sooner whether you’re having a heart attack or not.

It’s also a lot more reliable: If you measure a value now and you repeat that measurement again with the same blood sample, it doesn’t change very much compared to the old assays where there was a larger amount of analytical change.

Another potential benefit is greater prevention of cardiovascular disease. A recent study in JAMA Cardiology found that people with higher levels of troponin, even without having a heart attack, are more likely to develop heart failure. Your annual physical might one day include a routine check of troponin levels. If you have a big bump, that raises a warning flag.

How do current troponin tests for diagnosing heart attack fall short?

Korley: Up until now, most of the existing assays were only able to accurately measure troponin levels in the blood about six hours after the onset of injury, when the measurements get more reliable. If you had a measurement before six hours and it’s negative, you can’t be confident it’s truly negative. The first test may miss it.

If it’s positive, you’re done; it’s easy. But if it’s negative, we have to wait anywhere between three to six hours and then repeat the test -; depending on when a patient’s symptoms started -; before we can confidently say we don’t see signs of a heart attack.

How do accuracy levels differ between the two tests?

Korley: About 70 percent of people having a heart attack are going to have a positive result on the first blood draw (using the current troponin test). If it’s a big heart attack, we’re going to see it. Those having smaller heart attacks or those with a lot of blockage may have more delay.

Suffice to say, we’re in the business where 70 percent is not good enough. This new test is a lot higher: About 82 percent of those having a heart attack have elevated troponin levels even if the initial blood test is measured within six hours of onset of symptoms.

Beyond prompting heart attack treatment, how else does greater speed aid the process?

Korley: It’s closely tied to patient satisfaction, but also for the safety of other patients. As emergency physicians, the people we worry about the most are the people in the waiting room who we haven’t yet seen.

A significant proportion of emergency department visits are for chest pain. By being able to reduce the amount of time we spend answering whether a patient has had a heart attack, we’re able to focus a little bit more on other patients and decrease our wait times.

What are the downsides to high-sensitivity troponin testing?

Korley: In the past, very few people had noticeable elevations. Some time ago, we could only measure troponin levels in people having a big heart attack. Now, the assays are so sensitive we can measure it in healthy people. Most people have small amounts of circulating troponin.

With this test, then, we have to understand that elevations may sometimes be acute; some are chronic. For example, if someone has had uncontrolled blood pressure for a long time, that may cause damage to the heart. Therefore, if that person has an elevated troponin level, they might not require hospitalization. What they need is a good primary care doctor who can help them get their blood pressure down. Stress from an infection and injury to the brain can injure the heart as well.

As clinicians, we are going to need to be savvy in interpreting the results and not necessarily think that if someone’s troponin value is high the person is having a heart attack. Institutions have to learn how well the test is operating in their hands -; and how best to use it to derive the benefits. The rollout has to be cautious.

Tagged with:

About author

Related Articles